AzPA Pharmacy Flash

• Novel drug shows a signal to improve nHCM
  An investigative drug that uses a novel pathway to target cardiac metabolism was safe and well-tolerated and showed a signal to improve cardiac function in symptomatic patients with moderate nonobstructive hypertrophic cardiomyopathy in a phase 2 proof-of-concept trial.
• FDA expands approval of severe asthma drug
  The U.S. Food and Drug Administration expanded the approval of benralizumab to include treatment of younger kids with uncontrolled severe asthma with an eosinophilic phenotype, AstraZeneca announced recently.
• Drug shortages hit record high, pharmacists warn
  Drug shortages have reached an all-time high in the U.S., pharmacists are warning. During the first three months of 2024, there were 323 active medication shortages, according to the American Society of Health-System Pharmacists and Utah Drug Information Service.